Kelsey Goodwin

Stock Analyst at Guggenheim

(0.62)
# 3,749
Out of 4,820 analysts
17
Total ratings
33.33%
Success rate
-11.72%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Kelsey Goodwin

Century Therapeutics
Mar 28, 2025
Reiterates: Buy
Price Target: n/a
Current: $0.50
Upside: -
Genelux
Oct 29, 2024
Initiates: Buy
Price Target: $8
Current: $2.88
Upside: +177.78%
Nuvalent
Sep 16, 2024
Maintains: Buy
Price Target: $99$105
Current: $73.48
Upside: +42.90%
UroGen Pharma
Aug 22, 2024
Initiates: Buy
Price Target: $40
Current: $9.84
Upside: +306.50%
MacroGenics
Jul 31, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.70
Upside: -
2seventy bio
Sep 13, 2023
Downgrades: Neutral
Price Target: n/a
Current: $4.98
Upside: -
Arcellx
Jun 20, 2023
Maintains: Buy
Price Target: n/a
Current: $63.71
Upside: -
Legend Biotech
Oct 31, 2022
Initiates: Neutral
Price Target: n/a
Current: $34.28
Upside: -
Iovance Biotherapeutics
Oct 31, 2022
Initiates: Neutral
Price Target: n/a
Current: $3.51
Upside: -